What is it about?
Fabrication and characterisation of gold nanoparticles (GNPs) through reducing agents and different capped agents are one of their most attractive applications in biomedicine. GNPs are coated using various agents such as carbohydrate, amino acids, peptides and proteins. These capped gold nanoparticles (C-GNPs) are applied for wide different applications including drug delivery in the recent decade and potential treatment and diagnosis in drug delivery systems (DDS).
Featured Image
Why is it important?
Our study revealed that C-GNPs with anticancer drugs or new compounds could be potentially applied for biomedical usage especially in cancer therapy.
Perspectives
In this review, a well-defined description of C-GNPs and the application of these nanoparticles are discussed. Our study revealed that C-GNPs with anticancer drugs or new compounds could be potentially applied for biomedical usage especially in cancer therapy.
Dr Kamyar Khoshnevisan
Tehran University of Medical Sciences
Read the Original
This page is a summary of: The promising potentials of capped gold nanoparticles for drug delivery systems, Journal of Drug Targeting, October 2017, Taylor & Francis,
DOI: 10.1080/1061186x.2017.1387790.
You can read the full text:
Contributors
The following have contributed to this page
